Skye Bioscience (SKYE) Live Share Price, Invest From India

Skye Bioscience Stock Performance

as on November 13, 2026 at 7:58 am IST

Day's Low
Day's High
$0.86
Day's Price Range
$1.27
$1.07
19.63%
Downside
18.69%
Upside
52 Week's Low
52 Week's High
$0.50
52-Week Price Range
$12.72
$1.07
53.26%
Downside
1088.79%
Upside

Skye Bioscience share price movements today

Previous Close: $0.92
Open: $0.86
Volume: 464.4K
Market Cap: $3.7M
Day's Low - High: $0.86 - $1.27
52 Week Low - High: $0.50 - $12.72

Skye Bioscience Historical Returns

1 Month Return: -41.84 %
3 Month Return: -79.07 %
1 Year Return: -92.44 %
3 Year Return: -93.24 %
5 Year Return: 0 %

Skye Bioscience Stock Fundamentals & Key Indicators

Check Skye Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-10.16

Dividend Yield

0.00%

PE Ratio (TTM)

-0.08

Industry PE ratio

-2.55

PEG Ratio

0.00

Return On Equity TTM

-329.08%

Skye Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Skye Bioscience with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Skye Bioscience	NA	$3.7M	NA	-0.08	0.00%	0.00%
Moderna	Neutral	$101.5B	7.57%	-35.48	28.00%	0.00%
BeOne Medicines	StrongBuy	$48.4B	NA	68.25	88.39%	0.00%
Vertex Pharmaceuticals	StrongBuy	$138.9B	192.08%	34.99	85.57%	0.00%
Regeneron	Buy	$94.7B	52.00%	19.51	85.77%	0.40%

Stock Returns calculator for Skye Bioscience Stock including INR - Dollar returns

The Skye Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Skye Bioscience investment value today

Current value as on today

₹9,341

Returns

-₹90,659

(-90.66%)

Returns from Skye Bioscience Stock

-₹91,201 (-91.2%)

Dollar Impact

₹541 (+0.54%)

Indian Investors' Interest in Skye Bioscience Stock

Search interest for Skye Bioscience Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 14, 2026 to November 13, 2026

Change:-42% versus previous 30 day period

Skye Bioscience Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	-
Operating Income	-6	-8	-4	-10	-11	-18	-13	-14	-12	-11
EBITDA	-4	-7	-3	-9	-10	-17	-12	-14	-12	-10
Interest Expense	0	0	0	-	0	-	-	-	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-7	-3	-9	-11	-17	-12	-14	-12	-10
Income Tax Expense	0	0	-	-	0	0	-	-	-	0
Net Income	-5	-7	-3	-9	-11	-17	-12	-14	-12	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	0
Operating Income	-3	-4	-6	-6	-7	-18	-34	-30	-58
EBITDA	-3	-4	2	-5	-7	-18	-36	-25	-55
Interest Expense	0	0	1	0	0	0	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-19	1	-6	-8	-19	-37	-26	-55
Income Tax Expense	0	0	0	0	0	0	0	0	0
Net Income	-3	-19	1	-6	-8	-19	-37	-26	-55
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-5	-7	-3	-9	-11	-17	-12	11,077	-12	-10
Operating Cash Flow	-4	-7	-5	-8	-9,185	-10	-13	-9	-8	-7
Investing Cash Flow	1	0	-1	0	-12,808	-11	7	-2	10	7
Financing Cash Flow	85	-2	-	0	-	0	-	0	0	0
Change in Cash	82	-9	-6	-8	-21,994	-22	-5	-12	2	0

Skye Bioscience Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-19	1	-6	-8	-19	-37	-26	-55
Operating Cash Flow	-3	-3	-6	-6	-6	-12	-13	-25	-43
Investing Cash Flow	0	0	-	0	0	5	6	0	-19
Financing Cash Flow	3	5	6	6	13	0	16	83	0
Change in Cash	0	1	0	0	6	-7	9	58	-62

Global Institutional Holdings in Skye Bioscience

Check out the Institutions with significant holdings in Skye Bioscience.

Funds	Holdings
Brad Bolzon	45.35%
Felix Baker	35.58%
Punit Dhillon	32.28%
5AM Partners VII, LLC	22.16%
Andrew Schwab	22.16%

See all

Insights on Skye Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 831.1% return, outperforming this stock by 923.5%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 255.0% return, outperforming this stock by 348.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, SKYE stock has moved down by -11.6%

About Skye Bioscience

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Organisation	Skye Bioscience
Headquarters	11250 El Camino Real, San Diego, CA, 92130, US
Industry	Biotechnology
CEO	Punit Dhillon

Key Management of Skye Bioscience

Name	Title
Mr. Punit S. Dhillon B.A.	President, CEO, Principal Financial & Accounting Officer & Director

FAQs

What is Skye Bioscience share price today?

Skye Bioscience share price today is $1.07 as on November 13, 2026 at 2:28 am IST at the close of the market. Skye Bioscience share today touched a day high of $1.27 and a low of $0.86.

What is the 52 week high and 52 week low for Skye Bioscience share?

Skye Bioscience share touched a 52 week high of $12.72 on November 12, 2025 and a 52 week low of $0.50 on November 9, 2026. Skye Bioscience stock price today i.e. November 13, 2026 at 2:28 am IST is closed at $1.07,which is 91.59% down from its 52 week high and 113.96% up from its 52 week low.

What is Skye Bioscience's market capitalisation today?

Skye Bioscience market capitalisation is $0.00T as on November 13, 2026 at 2:28 am IST.

How to invest in Skye Bioscience Stock (SKYE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Skye Bioscience on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Skye Bioscience Stock (SKYE) from India?

Indian investors can start investing in Skye Bioscience (SKYE) shares with as little as ₹94.04000091552734 or $1 (as of November 13, 2026 at 2:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹940.40 in Skye Bioscience stock (as per the Rupee-Dollar exchange rate as on November 13, 2026 at 2:47 am IST). Based on Skye Bioscience share’s latest price of $1.07 as on November 13, 2026 at 2:28 am IST, you will get 9.3458 shares of Skye Bioscience. Learn more about fractional shares .